These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 24021293)

  • 1. Evaluation of brain targeting and mucosal integrity of nasally administrated nanostructured carriers of a CNS active drug, clonazepam.
    Abdel-Bar HM; Abdel-Reheem AY; Awad GA; Mortada ND
    J Pharm Pharm Sci; 2013; 16(3):456-69. PubMed ID: 24021293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal brain-targeted clonazepam polymeric micelles for immediate control of status epilepticus: in vitro optimization, ex vivo determination of cytotoxicity, in vivo biodistribution and pharmacodynamics studies.
    Nour SA; Abdelmalak NS; Naguib MJ; Rashed HM; Ibrahim AB
    Drug Deliv; 2016 Nov; 23(9):3681-3695. PubMed ID: 27648847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PLGA Nanoparticles for Nose to Brain Delivery of Clonazepam: Formulation, Optimization by 32 Factorial Design, In Vitro and In Vivo Evaluation.
    Shah P; Sarolia J; Vyas B; Wagh P; Ankur K; Kumar MA
    Curr Drug Deliv; 2021; 18(6):805-824. PubMed ID: 32640955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A coupled bimodal SPECT-CT imaging and brain kinetics studies of zolmitriptan-encapsulated nanostructured polymeric carriers.
    Mandlik SK; Ranpise NS; Mohanty BS; Chaudhari PR
    Drug Deliv Transl Res; 2018 Jun; 8(3):797-805. PubMed ID: 29380155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacoscintigraphic evaluation of potential of lipid nanocarriers for nose-to-brain delivery of antidepressant drug.
    Alam MI; Baboota S; Ahuja A; Ali M; Ali J; Sahni JK; Bhatnagar A
    Int J Pharm; 2014 Aug; 470(1-2):99-106. PubMed ID: 24810241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nose-to-brain delivery of sumatriptan-loaded nanostructured lipid carriers: preparation, optimization, characterization and pharmacokinetic evaluation.
    Masjedi M; Azadi A; Heidari R; Mohammadi-Samani S
    J Pharm Pharmacol; 2020 Oct; 72(10):1341-1351. PubMed ID: 32579251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal delivery of doxepin: enhancing brain targeting efficiency utilizing nanostructured lipid carriers for a biopharmaceutics drug disposition classification system class-I drug.
    Patel HP; Vasandia AV; Jha R; Desai BV; Desai DT; Dedhiya PP; Vyas BA; Maulvi FA
    Pharm Dev Technol; 2024 Jul; 29(6):639-647. PubMed ID: 38980085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal mucoadhesive microemulsions of clonazepam: preliminary studies on brain targeting.
    Vyas TK; Babbar AK; Sharma RK; Singh S; Misra A
    J Pharm Sci; 2006 Mar; 95(3):570-80. PubMed ID: 16419051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agranulocytosis-Protective Olanzapine-Loaded Nanostructured Lipid Carriers Engineered for CNS Delivery: Optimization and Hematological Toxicity Studies.
    Gadhave DG; Tagalpallewar AA; Kokare CR
    AAPS PharmSciTech; 2019 Jan; 20(1):22. PubMed ID: 30604305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct nose-brain transport of benzoylecgonine following intranasal administration in rats.
    Chow HH; Anavy N; Villalobos A
    J Pharm Sci; 2001 Nov; 90(11):1729-35. PubMed ID: 11745730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal delivery of nanoparticle encapsulated tarenflurbil: A potential brain targeting strategy for Alzheimer's disease.
    Muntimadugu E; Dhommati R; Jain A; Challa VG; Shaheen M; Khan W
    Eur J Pharm Sci; 2016 Sep; 92():224-34. PubMed ID: 27185298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation of intranasal mucoadhesive temperature-mediated in situ gel containing ropinirole and evaluation of brain targeting efficiency in rats.
    Khan S; Patil K; Bobade N; Yeole P; Gaikwad R
    J Drug Target; 2010 Apr; 18(3):223-34. PubMed ID: 20030503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nose to Brain Delivery of Rivastigmine by In Situ Gelling Cationic Nanostructured Lipid Carriers: Enhanced Brain Distribution and Pharmacodynamics.
    Wavikar P; Pai R; Vavia P
    J Pharm Sci; 2017 Dec; 106(12):3613-3622. PubMed ID: 28923321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal microemulsion for targeted nose to brain delivery in neurocysticercosis: Role of docosahexaenoic acid.
    Shinde RL; Bharkad GP; Devarajan PV
    Eur J Pharm Biopharm; 2015 Oct; 96():363-79. PubMed ID: 26318978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fabrication of an ionic-sensitive in situ gel loaded with resveratrol nanosuspensions intended for direct nose-to-brain delivery.
    Hao J; Zhao J; Zhang S; Tong T; Zhuang Q; Jin K; Chen W; Tang H
    Colloids Surf B Biointerfaces; 2016 Nov; 147():376-386. PubMed ID: 27566226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nose-to-Brain Drug Delivery and Physico-Chemical Properties of Nanosystems: Analysis and Correlation Studies of Data from Scientific Literature.
    Bonaccorso A; Ortis A; Musumeci T; Carbone C; Hussain M; Di Salvatore V; Battiato S; Pappalardo F; Pignatello R
    Int J Nanomedicine; 2024; 19():5619-5636. PubMed ID: 38882536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intranasal mucoadhesive microemulsions of zolmitriptan: preliminary studies on brain-targeting.
    Vyas TK; Babbar AK; Sharma RK; Misra A
    J Drug Target; 2005 Jun; 13(5):317-24. PubMed ID: 16199375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoemulsion-based intranasal drug delivery system of saquinavir mesylate for brain targeting.
    Mahajan HS; Mahajan MS; Nerkar PP; Agrawal A
    Drug Deliv; 2014 Mar; 21(2):148-54. PubMed ID: 24128122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of novel bioadhesive granisetron hydrochloride spanlastic gel and insert for brain targeting and study their effects on rats.
    Abdelmonem R; El Nabarawi M; Attia A
    Drug Deliv; 2018 Nov; 25(1):70-77. PubMed ID: 29228824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal Surface-Modified Mosapride Citrate-Loaded Nanostructured Lipid Carriers (MOS-SMNLCs) for Treatment of Reflux Diseases: In vitro Optimization, Pharmacodynamics, and Pharmacokinetic Studies.
    Hammad RW; Sanad RAB; Abdelmalk NS; Aziz RL; Torad FA
    AAPS PharmSciTech; 2018 Nov; 19(8):3791-3808. PubMed ID: 30280358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.